HSBC downgrades Nike stock rating on turnaround uncertainty By Investing.com

HSBC downgraded Nike to Hold from Buy and slashed its price target to $48 from $90, citing limited visibility on the recovery and cutting fiscal 2026-2028 EBIT estimates by 35%. Nike is trading at $42.62, near its 52-week low of $42.36, amid ongoing weakness in Converse, China, EMEA and sportswear. Other analysts also turned more cautious, including Piper Sandler and RBC, while third-quarter fiscal 2026 gross margin fell 130bps to 40.2%.

Analysis

This is less a single-earnings disappointment than a widening of the terminal-value discount on the brand. When multiple sell-side shops cut fair value simultaneously while management turnover remains elevated in innovation and product, the market starts pricing a longer period of promotional intensity, not just a slower recovery. That matters because apparel and footwear turnarounds usually fail when gross margin repair is pushed out beyond 2-3 seasons; the incremental risk is not just lower EBIT, but a higher working-capital burden as inventory must be supported through discounting.

The second-order winner is not a direct rival by brand, but any lower-beta retailer or athleticwear name with cleaner inventory and more disciplined channel mix. If Nike stays on the defensive, wholesale partners will demand better terms and chase fill rates from alternative vendors, which can support shelf space for smaller performance brands and private-label programs. More importantly, continued weakness in China and EMEA can force broader promo behavior across the category, compressing industry margins rather than just Nike’s, especially into the next two quarters.

The stock is approaching a zone where the risk/reward gets binary: a rerate requires evidence of sell-through, not just strategy commentary. Near term, the most likely catalyst is not a positive surprise, but either another margin guide-down or signs that a major product refresh is failing to ignite full-price demand; both would pressure the shares further over the next 30-60 days. The contrarian angle is that expectations may already embed a lot of bad news, so the setup for a tactical bounce exists if inventory normalizes faster than feared or if management can show cleaner demand in North America by the next print, but that is a show-me trade rather than a fundamental bottom.

Key Decisions for Investors

• Short NKE on strength for a 1-3 month horizon; use rallies toward resistance to build the position. Risk/reward favors downside until there is visible full-price sell-through, with stop discipline above the pre-downgrade recovery range.
• Pair trade: long a cleaner athletic/retail beneficiary vs short NKE over the next 1-2 quarters. The goal is to isolate category share shift and margin dispersion rather than macro consumer risk.
• Buy near-dated NKE puts or put spreads into the next earnings/update window. This expresses the view that the market is still underpricing another margin or outlook reset, while limiting premium outlay.
• Watch for a tactical long only if channel inventory and gross margin stabilize for one full quarter; otherwise, fading rallies remains the higher-conviction trade. If that setup appears, target a short-covering bounce rather than a structural re-rating.
• Avoid owning NKE as a turn-around beta until management credibility improves; the better risk/reward is to wait for evidence before paying for the recovery narrative.